Action 300529 JAFRON BIOMEDICAL CO.,LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Jafron Biomedical Co.,Ltd.

Actions

300529

CNE100002995

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 25/04/2024 		Varia. 5j. Varia. 1 janv.
23,3 CNY +1,84 % Graphique intraday de Jafron Biomedical Co.,Ltd. +3,56 % +4,81 %
25/04 Jafron Biomedical Co. présente ses résultats pour le premier trimestre clos le 31 mars 2024 CI
2023 Jafron Biomedical Co. publie ses résultats pour les neuf mois se terminant le 30 septembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.
Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.
Jafron Biomedical Co.,Ltd.'s Equity Buyback announced on July 17, 2023, has closed with 24,242,904 shares, representing 3% for CNY 500 million.
Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Zhuhai Jianfu Pharmaceutical Co., Ltd. announced that it expects to receive CNY 15 million in funding from Jafron Biomedical Co.,Ltd.
Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Jafron Biomedical Co.,Ltd. announces an Equity Buyback for CNY 500 million worth of its shares.
Jafron Biomedical Co.,Ltd. authorizes a Buyback Plan.
Jafron Biomedical Co.,Ltd. Announces Cash Dividend on A Shares for the Year 2022, Payable on 31 May 2023
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Jafron Biomedical Co.,Ltd. Approves the Cash Dividend for 2022
Jafron Biomedical Co.,Ltd. Approves Director Elections
Jafron Biomedical Co.,Ltd. Announces Profit Distribution Proposal for 2022
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Jafron Biomedical Co.,Ltd. Implements Final Cash Dividend (A Shares) for 2021, Payable on 10 June 2022
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 300529
  4. Actualités Jafron Biomedical Co.,Ltd.
  5. Autres langues